NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 18 filers reported holding NEPHROS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,114 | -4.5% | 4,131 | 0.0% | 0.00% | – |
| Q2 2023 | $6,403 | +44.9% | 4,131 | 0.0% | 0.00% | – |
| Q1 2023 | $4,420 | -7.5% | 4,131 | 0.0% | 0.00% | – |
| Q4 2022 | $4,780 | +19.5% | 4,131 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 4,131 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -92.3% | 4,131 | -76.7% | 0.00% | – |
| Q1 2022 | $78,000 | -28.4% | 17,750 | -4.0% | 0.00% | – |
| Q4 2021 | $109,000 | -31.0% | 18,489 | +2.3% | 0.00% | – |
| Q3 2021 | $158,000 | -33.6% | 18,079 | -23.0% | 0.00% | – |
| Q2 2021 | $238,000 | +51.6% | 23,474 | -0.4% | 0.00% | – |
| Q1 2021 | $157,000 | -6.5% | 23,559 | +20.9% | 0.00% | – |
| Q4 2020 | $168,000 | +27.3% | 19,488 | +6.3% | 0.00% | – |
| Q3 2020 | $132,000 | -38.3% | 18,333 | -28.1% | 0.00% | – |
| Q2 2020 | $214,000 | +296.3% | 25,484 | +194.3% | 0.00% | – |
| Q1 2020 | $54,000 | +116.0% | 8,659 | +238.0% | 0.00% | – |
| Q4 2019 | $25,000 | – | 2,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,687,438 | $5,457,408 | 1.21% |
| BARD ASSOCIATES INC | 186,039 | $275,338 | 0.11% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,341 | $67 | 0.04% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 71,037 | $106,228 | 0.00% |
| STATE STREET CORP | 15,698 | $23,469 | 0.00% |
| MORGAN STANLEY | 15,292 | $22,632 | 0.00% |
| BLAIR WILLIAM & CO/IL | 36,249 | $53,649 | 0.00% |
| BlackRock Inc. | 4,131 | $6,114 | 0.00% |
| HighTower Advisors, LLC | 56,710 | $83,000 | 0.00% |